{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:03:12Z","timestamp":1785452592493,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32AR080618"],"award-info":[{"award-number":["T32AR080618"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007557","name":"California Institute of Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007557","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bonr.2026.101921","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:06:56Z","timestamp":1778764016000},"page":"101921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Lipid nanoparticles for nucleic acid delivery to osteoblasts and osteoblast-lineage cells: A systematic review"],"prefix":"10.1016","volume":"29","author":[{"given":"Alexander I.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.","family":"Pomerantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2026.101921_bb0080","series-title":"A Comprehensive List of COVID-19 Vaccine Ingredients","year":"2021"},{"key":"10.1016\/j.bonr.2026.101921_bb0005","series-title":"The Onpattro Story and the Clinical Translation of Nanomedicines Containing Nucleic Acid-Based Drugs","author":"Akinc","year":"2019"},{"key":"10.1016\/j.bonr.2026.101921_bb0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2024.08.016","article-title":"The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA","volume":"374","author":"Barbieri","year":"2024","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.bonr.2026.101921_bb0015","article-title":"Lipid nanoparticle delivery of siRNA to osteocytes leads to effective silencing of SOST and inhibition of Sclerostin in vivo","volume":"5","author":"Basha","year":"2016","journal-title":"Mol. Ther. Nucleic Acids."},{"issue":"9","key":"10.1016\/j.bonr.2026.101921_bb0020","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1016\/j.ymthe.2022.06.012","article-title":"Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo","volume":"30","author":"Basha","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bonr.2026.101921_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2014.09.025","article-title":"Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration","volume":"196","author":"Chen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bonr.2026.101921_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.bonr.2026.101921_bb0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bonr.2026.101921_bb0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \u201cPEG dilemma\u201d in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bonr.2026.101921_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"eBioMedicine"},{"issue":"4","key":"10.1016\/j.bonr.2026.101921_bb0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today."},{"issue":"1","key":"10.1016\/j.bonr.2026.101921_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bonr.2026.101921_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"43","key":"10.1016\/j.bonr.2026.101921_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310401","article-title":"A multidimensional approach to modulating ionizable lipids for high-performing and organ-selective mRNA delivery","volume":"62","author":"He","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.bonr.2026.101921_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.bonr.2026.101921_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.bonr.2026.101921_bb0085","first-page":"758","article-title":"Delivery of GAS5 by LNP promotes tendon-bone healing in rotator cuff injury","volume":"51","author":"Li","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bonr.2026.101921_bb0090","article-title":"LNP targeted Pcolce mRNA delivery and calcium supplementation synergistically attenuate osteoporosis","volume":"525","author":"Li","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"3","key":"10.1016\/j.bonr.2026.101921_bb0095","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nm.3791","article-title":"Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy","volume":"21","author":"Liang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bonr.2026.101921_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102074","article-title":"Delivery of m7G methylated Runx2 mRNA by bone-targeted lipid nanoparticle promotes osteoblastic bone formation in senile osteoporosis","volume":"54","author":"Liu","year":"2024","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.bonr.2026.101921_bb0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4248\/BR201303001","article-title":"The key role of the blood supply to bone","volume":"1","author":"Marenzana","year":"2013","journal-title":"Bone Res."},{"issue":"4","key":"10.1016\/j.bonr.2026.101921_bb0110","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1039\/D4PM00128A","article-title":"Tailoring lipid nanoparticle dimensions through manufacturing processes","volume":"1","author":"McMillan","year":"2024","journal-title":"Rsc Pharm."},{"issue":"6","key":"10.1016\/j.bonr.2026.101921_bb0115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater Au."},{"issue":"6","key":"10.1016\/j.bonr.2026.101921_bb0120","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ymthe.2022.04.011","article-title":"Pro-inflammatory concerns with lipid nanoparticles","volume":"30","author":"Moghimi","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bonr.2026.101921_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115446","article-title":"Breaking the final barrier: evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome","volume":"214","author":"Mrksich","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bonr.2026.101921_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102440","article-title":"Nucleic acid therapeutics: past, present, and future","volume":"36","author":"Naeem","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.bonr.2026.101921_bb0135","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/ijms24010787","article-title":"Nanoparticles in clinical trials: analysis of clinical trials, FDA approvals and use for COVID-19 vaccines","volume":"24","author":"Namiot","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bonr.2026.101921_bb0140","series-title":"Nanotechnology at NIH","author":"National Institutes of Health (NIH)","year":"2026"},{"issue":"39","key":"10.1016\/j.bonr.2026.101921_bb0145","first-page":"273","article-title":"\u03b2-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model","volume":"23","author":"Nelson","year":"2024","journal-title":"Bioact. Mater."},{"issue":"3","key":"10.1016\/j.bonr.2026.101921_bb0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/acs.accounts.1c00560","article-title":"How do biomolecules cross the cell membrane?","volume":"55","author":"Pei","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bonr.2026.101921_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2010.66","article-title":"Development of DNA aptamers using cell-SELEX","author":"Sefah","year":"2010","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.bonr.2026.101921_bb0160","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.bonr.2026.101921_bb0165","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/vaccines9040359","article-title":"Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines","volume":"9","author":"Thi","year":"2021","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.bonr.2026.101921_bb0170","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/10611861003622560","article-title":"Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration","volume":"18","author":"Wang","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bonr.2026.101921_bb0175","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jconrel.2024.08.030","article-title":"Enhancing RNA-lipid nanoparticle delivery: organ- and cell-specificity and barcoding strategies","volume":"375","author":"Wei","year":"2024","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.bonr.2026.101921_bb0180","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.7150\/thno.95423","article-title":"Osteoblast-specific down-regulation of NLRP3 inflammasome by aptamer-functionalized liposome nanoparticles improves bone quality in postmenopausal osteoporosis rats","volume":"14","author":"Xu","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bonr.2026.101921_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"npj Vaccines"},{"issue":"31","key":"10.1016\/j.bonr.2026.101921_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402117","article-title":"Targeting osteoblast-osteoclast cross-talk bone homeostasis repair microcarriers promotes intervertebral fusion in osteoporotic rats","volume":"13","author":"Zheng","year":"2024","journal-title":"Adv. Healthc. Mater."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:57:50Z","timestamp":1783148270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187226000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S2352187226000252"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101921","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticles for nucleic acid delivery to osteoblasts and osteoblast-lineage cells: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101921"}}